John Libbey Eurotext

Psychologie & NeuroPsychiatrie du vieillissement

L'atrophie multisystématisée Volume 8, numéro 3, septembre 2010

1 Dejerine J. L'atrophie olivo-ponto-cérébelleuse. Nouvelle iconographie de la Salpêtrière, 1900 ; : 330-70.

2 Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension : a clinical-pathologic study. Arch Neurol 1960 ; 2 : 511-27.

3 Adams RD, Vanbogaert L, Vandereecken H. Striato-nigral degeneration. J Neuropathol Exp Neurol 1964 ; 23 : 584-608.

4 Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969 ; 32 : 28-34.

5 Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994 ; 117 : 235-43.

6 Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004 ; 3 : 93-103.

7 Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy : a review of 203 pathologically proven cases. Mov Disord 1997 ; 12 : 133-47.

8 Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008 ; 71 : 670-6.

9 Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Mov Disord 2008 : S255.

10 Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007 ; 33 : 615-20.

11 Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy ? Neurology 2002 ; 59 : 1486-91.

12 Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy : clinical and laboratory features in 30 patients. Mov Disord 2008 ; 23 : 977-84.

13 Bonnet AM, Pichon J, Vidailhet M, Gouider-Khouja N, Robain G, Perrigot M, et al. Urinary disturbances in striatonigral degeneration and Parkinson's disease : clinical and urodynamic aspects. Mov Disord 1997 ; 12 : 509-13.

14 Wenning GK, Scherfler C, Granata R, Bosch S, Verny M, Chaudhuri KR, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999 ; 67 : 620-3.

15 Oertel WH, Wachter T, Quinn NP, Ulm G, Brandstadter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord 2003 ; 18 : 430-2.

16 Klein C, Brown R, Wenning G, Quinn N. The “cold hands sign” in multiple system atrophy. Mov Disord 1997 ; 12 : 514-8.

17 Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002 ; 72 : 798-800.

18 Tison F, Wenning GK, Quinn NP, Smith SJ. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995 ; 58 : 379-80.

19 Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000 ; 15 : 699-704.

20 Benarroch EE. Brainstem respiratory control : substrates of respiratory failure of multiple system atrophy. Mov Disord 2007 ; 22 : 155-61.

21 Tison F, Wenning GK, Volonte MA, Poewe WR, Henry P, Quinn NP. Pain in multiple system atrophy. J Neurol 1996 ; 243 : 153-6.

22 Dujardin K, Defebvre L, Krystkowiak P, Degreef JF, Destée A. Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord 2003 ; 9 : 205-11.

23 Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, et al. Cognitive impairments in multiple system atrophy : MSA-C vs MSA-P. Neurology 2008 ; 70 : 1390-6.

24 Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000 ; 54 : 697-702.

25 Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F, et al. Progression of putaminal degeneration in multiple system atrophy : a serial diffusion MR study. Neuroimage 2006 ; 31 : 240-5.

26 Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG- PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005 ; 26 : 912-21.

27 Pellecchia MT, Pivonello R, Colao A, Barone P. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. Clin Med Res 2006 ; 4 : 322-5.

28 Sénard JP, Pavy-Le Traon A, Tison F. Explorations du système nerveux autonome. In : Tison F, ed. Les syndromes parkinsoniens atypiques et secondaires. Paris : Masson, 2006 : 92-105.

29 Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders : the NNIPPS study. Brain 2009 ; 132 : 156-71.

30 Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, et al. Red flags for multiple system atrophy. Mov Disord 2008 ; 23 : 1093-9.

31 Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease : a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992 ; 55 : 181-4.

32 Sénard JM, Rai S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997 ; 63 : 584-9.

33 Wullner U, Schmitz-Hubsch T, Antony G, Fimmers R, Spottke A, Oertel WH, et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.) : the effect of ageing. Eur J Neurol 2007 ; 14 : 1405-8.

34 Williams DR, Lees AJ. Progressive supranuclear palsy : clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009 ; 8 : 270-9.

35 Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration : a clinicopathologic study. Neurology 1997 ; 48 : 119-25.

36 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies : third report of the DLB Consortium. Neurology 2005 ; 65 : 1863-72.

37 Goizet C BG, Tison F. Atrophies (dégénérescences) cérébelleuses tardives. Encyclopédie Médico-Chirurgicale, Neurologie. Paris : Elsevier, 2002 : 17-063-D-010, 061-018.

38 Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias : clinical features, genetics, and pathogenesis. Lancet Neurol 2004 ; 3 : 291-304.

39 Schmitz-Hubsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6 : disease severity and nonataxia symptoms. Neurology 2008 ; 71 : 982-9.

40 Gilman S, Little R, Johanns J, Heumann M, Kluin KJ, Junck L, et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000 ; 55 : 527-32.

41 Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996 ; 46 : 1470.

42 Wenning GK, Geser F, Poewe W. Therapeutic strategies in multiple system atrophy. Mov Disord 2005 ; 20 (Suppl. 12) : S67-S76.

43 Rajrut AH, Uitti RJ, Fenton ME, George D. Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 1997 ; 3 : 211-4.

44 Wenning GK. Placebo-controlled trial of amantadine in multiple-system atrophy. Clin Neuropharmacol 2005 ; 28 : 225-7.

45 Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, et al. Neurogenic orthostatic hypotension : a double-blind, placebo-controlled study with midodrine. Am J Med 1993 ; 95 : 38-48.

46 Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006 ; 63 : 513-8.

47 Low PA, Singer W. Management of neurogenic orthostatic hypotension : an update. Lancet Neurol 2008 ; 7 : 451-8.

48 Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 2003 ; 13 : 106-8.

49 Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001 ; 71 : 371-4.

50 Ghorayeb I, Yekhlef F, Bioulac B, Tison F. Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy : long-term acceptance. Sleep Med 2005 ; 6 : 359-62.

51 Ramig LO, Sapir S, Countryman S, Pawlas AA, O'Brien C, Hoehn M, et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease : a 2 year follow up. J Neurol Neurosurg Psychiatry 2001 ; 71 : 493-8.

52 Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003 ; 18 : 685-8.